Jumped in this AM.
Read their website last night, and really like what they are doing. I'm involved in the medical industry so was able to dig more into their R&D and technologies. We may have a real winner here, since the worldwide population is ageing.
Read their website last night, and really like what they are doing. I'm involved in the medical industry so was able to dig more into their R&D and technologies. We may have a real winner here, since the worldwide population is ageing.
Recent KPRX News
- Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway • Newsfile • 04/14/2026 11:00:00 AM
- Kiora Pharmaceuticals Announces Management Team Changes • Newsfile • 04/02/2026 08:30:00 PM
- Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials • Newsfile • 03/25/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:36:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 07:03:53 PM
- Kiora Pharmaceuticals to Present at Oppenheimer's 36th Annual Healthcare Life Sciences Conference • Newsfile • 02/19/2026 01:30:00 PM
- Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds • Newsfile • 12/01/2025 11:45:00 AM
- Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases • Newsfile • 11/07/2025 11:00:00 AM
- Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders • PR Newswire (US) • 10/30/2025 01:00:00 PM
- Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025 • Newsfile • 10/15/2025 11:00:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/15/2025 08:15:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 11:14:26 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 11:01:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 06:34:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 11:00:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2025 11:02:08 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 10:59:55 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2025 02:00:09 PM
